Smith Anglin Financial, LLC
- SEC CIK
- 0001553540
- Latest filing
- Jul 17, 2025
PFE holding history
Pfizer Inc in every 13F filed by Smith Anglin Financial, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2025 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −10,211−100.0% | Sold out | Holders |
| Q1 2025 | 10,211 | $258.8K | <0.1% | +2,418+31.0% | Added | Holders |
| Q4 2024 | 7,793 | $206.7K | <0.1% | −14,728−65.4% | Reduced | Holders |
| Q3 2024 | 22,521 | $651.8K | 0.1% | +495+2.2% | Added | Holders |
| Q2 2024 | 22,026 | $616.3K | 0.1% | +1,472+7.2% | Added | Holders |
| Q1 2024 | 20,554 | $570.4K | 0.1% | +10,716+108.9% | Added | Holders |
| Q4 2023 | 9,838 | $283.2K | <0.1% | −2,607−20.9% | Reduced | Holders |
| Q3 2023 | 12,445 | $412.8K | 0.1% | +136+1.1% | Added | Holders |
| Q2 2023 | 12,309 | $451.5K | 0.1% | +3,343+37.3% | Added | Holders |
| Q1 2023 | 8,966 | $365.8K | 0.1% | +36+0.4% | Added | Holders |
| Q4 2022 | 8,930 | $457.6K | 0.1% | −582−6.1% | Reduced | Holders |
| Q3 2022 | 9,512 | $416.0K | 0.1% | −24−0.3% | Reduced | Holders |
| Q2 2022 | 9,536 | $500.0K | 0.1% | +28+0.3% | Added | Holders |
| Q1 2022 | 9,508 | $492.0K | 0.1% | −562−5.6% | Reduced | Holders |
| Q4 2021 | 10,070 | $595.0K | 0.1% | +4,794+90.9% | Added | Holders |
| Q3 2021 | 5,276 | $227.0K | <0.1% | −364−6.5% | Reduced | Holders |
| Q2 2021 | 5,640 | $221.0K | <0.1% | +5,640 | New | Holders |